Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium

Короткий зміст

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for equine use of hyaluronate sodium injection containing 11 milligrams hyaluronate sodium per milliliter (mg/mL) rather than the currently approved 10 mg/mL.